Classys nears 50,000 devices sold globally

CLASSYS Inc., a South Korean medical aesthetics company listed on KOSDAQ, announced on August 25, 2026 that it expects global device sales to surpass 50,000 units this year. The company has expanded its portfolio beyond its traditional HIFU and MRF devices to include MNRF, laser, and dermabrasion systems. As of end of June, CLASSYS had cumulative global installations of over 22,000 HIFU units, over 4,000 MRF units, and over 6,000 each for MNRF and dermabrasion lines. The company reported consolidated revenue of KRW 192.7 billion for the first half of 2026, a 20% year-over-year increase, with exports (excluding shipments to its Brazilian subsidiary) growing 29% year-over-year. Standalone operating margin reached 50.8%. Consumables revenue grew to KRW 80.2 billion, up 5.3% year-over-year. CLASSYS plans to launch its Quadessy platform globally and its Viclara dermabrasion device in Europe later this year. The company is expanding in European markets including the UK, Sweden, Netherlands, Finland, Hungary, and Bulgaria. Yugene Choi, Head of Investor Relations, highlighted the company's growing global reach and plans to drive continued growth in device and consumables sales.